Senescence-accelerated mice (SAMs) as a model for brain aging and immunosenescence

Aging and Disease

Volumn 2, Issue 5, 2011, Pages 414-436

  Shimada, Atsuyoshi ^a   Hasegawa Ishii, Sanae ^a  

^a INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

Author keywords

Brain aging; CD4; Immunosenescence; Model; Senescence accelerated mice; T cells

Indexed keywords

MUS;

EID: 84873458549     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: None     Document Type: Review

References (168)

1. Takeda T (2009). Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice. Neurochem Res, 34: 639-659.
2. Sprott RL, Austad SN. (2006). Historical Development of Animal Models of Aging. In: Conn PM, editor. Handbook of Models for Human Aging: Elsevior Academic Press, 1-8.
3. Mori M, Higuchi K. (2004). Genetic monitoring system for SAM strains utilizing DNA markers In: Nomura Y, Takeda T, Okuma Y, editors. The Senescence-Accerelated Mouse (SAM): An Animal Model of Senescence. Amsterdam: Elsevier, 187-190.
4. Dickstein DL, Kabaso D, Rocher AB, Luebke JI, Wearne SL, Hof PR (2007). Changes in the structural complexity of the aged brain. Aging Cell, 6: 275-284.
5. Barnes CA (1994). Normal aging: regionally specific changes in hippocampal synaptic transmission. Trends Neurosci, 17: 13-18.
6. Jacobs B, Driscoll L, Schall M (1997). Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. J Comp Neurol, 386: 661-680.
7. Hof PR, Duan H, Page TL, Einstein M, Wicinski B, He Y, Erwin JM, Morrison JH (2002). Age-related changes in GluR2 and NMDAR1 glutamate receptor subunit protein immunoreactivity in corticocortically projecting neurons in macaque and patas monkeys. Brain Res, 928: 175-186.
8. Duan H, Wearne SL, Rocher AB, Macedo A, Morrison JH, Hof PR (2003). Age-related dendritic and spine changes in corticocortically projecting neurons in macaque monkeys. Cereb Cortex, 13: 950-961.
9. Chang YM, Rosene DL, Killiany RJ, Mangiamele LA, Luebke JI (2005). Increased action potential firing rates of layer 2/3 pyramidal cells in the prefrontal cortex are significantly related to cognitive performance in aged monkeys. Cereb Cortex, 15: 409-418.
10. Ron-Harel N, Schwartz M (2009). Immune senescence and brain aging: can rejuvenation of immunity reverse memory loss? Trends Neurosci, 32: 367-375.
11. Kirkwood TB (2005). Understanding the odd science of aging. Cell, 120: 437-447.
12. Yirmiya R, Goshen I (2011). Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun, 25: 181-213.
13. Sparkman NL, Johnson RW (2008). Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation, 15: 323-330.
14. von Bernhardi R, Tichauer JE, Eugenin J (2010). Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. J Neurochem, 112: 1099-1114.
15. Gemma C (2010). Neuroimmunomodulation and Aging. Aging Dis, 1: 169-172.
16. Perry VH (2010). Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol, 120: 277-286.
17. Johnson RW, Godbout JP. (2007). Aging, Neuroinflammation, and Behavior. In: Ader R, editor. Psychoneuroimmunology. 4th edn. Amsterdam: Elsevier Acdemic Press, 379-391.
18. Lucin KM, Wyss-Coray T (2009). Immune activation in brain aging and neurodegeneration: too much or too little? Neuron, 64: 110-122.
19. Ye SM, Johnson RW (1999). Increased interleukin-6 expression by microglia from brain of aged mice. J Neuroimmunol, 93: 139-148.
20. Ye SM, Johnson RW (2001). An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice. Neuroimmunomodulation, 9: 183-192.
21. Ye SM, Johnson RW (2001). Regulation of interleukin-6 gene expression in brain of aged mice by nuclear factor kappaB. J Neuroimmunol, 117: 87-96.
22. Dilger RN, Johnson RW (2008). Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J Leukoc Biol, 84: 932-939.
23. Amano T, Nakanishi H, Oka M, Yamamoto K (1995). Increased expression of cathepsins E and D in reactive microglial cells associated with spongiform degeneration in the brain stem of senescence-accelerated mouse. Exp Neurol, 136: 171-182.
24. Neumann H, Kotter MR, Franklin RJ (2009). Debris clearance by microglia: an essential link between degeneration and regeneration. Brain, 132: 288-295.
25. Nimmerjahn A, KirchhoffF, Helmchen F (2005). Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science, 308: 1314-1318.
26. Streit WJ, Xue QS (2009). Life and death of microglia. J Neuroimmune Pharmacol, 4: 371-379.
27. Streit WJ (2006). Microglial senescence: does the brain's immune system have an expiration date? Trends Neurosci, 29: 506-510.
28. Conde JR, Streit WJ (2006). Microglia in the aging brain. J Neuropathol Exp Neurol, 65: 199-203.
29. Streit WJ, Xue Q-S (2010). The brain's aging immune system. Aging Dis, 1: 254-261.
30. Bachstetter AD, Van Eldik LJ (2010). The p38 MAP kinase family as regulators of proinflammatory cytokine production in degenerative diseases of the CNS. Aging Dis, 1: 199-211.
31. Barrientos RM, Frank MG, Watkins LR, Maier SF (2010). Memory impairments in healthy aging: Role of aging-induced microglial sensitization. Aging Dis, 1: 212-231.
32. Gemma C, Bachstetter AD, Bickford PC (2010). Neuron-microglia dialogue and hippocampal neurogenesis in the aged brain. Aging Dis, 1: 232-244.
33. Lynch AM, Murphy KJ, Deighan BF, O'Reilly J-A, Gun'ko YK, Cowley TR, Gonzalez-Reyes RE, Lynch MA (2010). The impact of glial activation in the aging brain. Aging Dis, 1: 262-278.
34. Toichi E, Hanada K, Hosono M, Hosokawa T, Hosokawa M, Baba M, Imamura S, Takeda T. (1994). Early decline of T cell function in humoral immunity and long-lasting inflammatory T cell activity in aging SAM mice In: Takeda T, editor. The SAM model of senescence. Amsterdam: Excerpta Medica, 175-178.
35. Yoshioka H, Yoshida H, Doi T, Muso E, Ohshio G, Higuchi K, Inada M, Miyake T, Kita T, Hamashima Y, et al. (1989). Autoimmune abnormalities in a murine model of accelerated senescence. Clin Exp Immunol, 75: 129-135.
36. Hosokawa T, Hosono M, Higuchi K, Aoike A, Kawai K, Takeda T (1987). Immune responses in newly developed short-lived SAM mice. I. Age-associated early decline in immune activities of cultured spleen cells. Immunology, 62: 419-423.
37. Hosokawa T, Hosono M, Hanada K, Aoike A, Kawai K, Takeda T (1987). Immune responses in newly developed short-lived SAM mice. Selectively impaired T-helper cell activity in in vitro antibody response. Immunology, 62: 425-429.
38. Nishimura Y, Hosokawa T, Hosono M, Baba M, Hosokawa M (2002). Insufficient interleukin-2 production from splenic CD4+ T cells causes impaired cell proliferation and early apoptosis in SAMP1, a strain of senescence-accelerated mouse. Immunology, 107: 190-198.
39. Hosokawa T. (2004). Immune system deficiencies in SAM. In: Nomura Y, Takeda T, Okuma Y, editors. The Senescence-Accerelated Mouse (SAM): An Animal Model of Senescence. Amsterdam: Elsevier, 41-46.
40. Sanders VM, Munson AE (1984). Beta adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro. J Pharmacol Exp Ther, 230: 183-192.
41. Hosono M, Hanada K, Toichi E, Naiki H, Higuchi K, Hosokawa T (1997). Immune abnormality in relation to nonimmune diseases in SAM mice. Exp Gerontol, 32: 181-195.
42. Toichi E, Hanada K, Hosokawa T, Higuchi K, Hosokawa M, Imamura S, Hosono M (1997). Age-related decline in humoral immunity caused by the selective loss of TH cells and decline in cellular immunity caused by the impaired migration of inflammatory cells without a loss of TDTH cells in SAMP1 mice. Mech Ageing Dev, 99: 199-217.
43. Haruna H, Inaba M, Inaba K, Taketani S, Sugiura K, Fukuba Y, Doi H, Toki J, Tokunaga R, Ikehara S (1995). Abnormalities of B cells and dendritic cells in SAMP1 mice. Eur J Immunol, 25: 1319-1325.
44. Dong L, Mori I, Hossain MJ, Kimura Y (2000). The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection. J Infect Dis, 182: 391-396.
45. Liu B, Kimura Y (2007). Local immune response to respiratory syncytial virus infection is diminished in senescence-accelerated mice. J Gen Virol, 88: 2552-2558.
46. Abe Y, Yuasa M, Kajiwara Y, Hosono M (1994). Defects of immune cells in the senescence-accelerated mouse: a model for learning and memory deficits in the aged. Cell Immunol, 157: 59-69.
47. Shimada A, Ohta A, Akiguchi I, Takeda T (1992). Inbred SAM-P/10 as a mouse model of spontaneous, inherited brain atrophy. J Neuropathol Exp Neurol, 51: 440-450.
48. Shimada A (1999). Age-dependent cerebral atrophy and cognitive dysfunction in SAMP10 mice. Neurobiol Aging, 20: 125-136.
49. Shimada A, Hosokawa M, Ohta A, Akiguchi I, Takeda T (1994). Localization of atrophy-prone areas in the aging mouse brain: Comparison between the brain atrophy model SAM-P/10 and the normal control SAM-R/1. Neuroscience, 59: 859-869.
50. Shimada A, Tsuzuki M, Keino H, Satoh M, Chiba Y, Saitoh Y, Hosokawa M (2006). Apical vulnerability to dendritic retraction in prefrontal neurones of ageing SAMP10 mouse: a model of cerebral degeneration. Neuropathol and Appl Neurobiol, 32: 1-14.
51. Shimada A, Keino H, Satoh M, Kishikawa M, Hosokawa M (2003). Age-related loss of synapses in the frontal cortex of SAMP10 mouse: A model of cerebral degeneration. Synapse, 48: 198-204.
52. Shimada A, Ohta A, Akiguchi I, Takeda T (1993). Age-related deterioration in conditional avoidance task in the SAM-P/10 mouse, an animal model of spontaneous brain atrophy. Brain Res, 608: 266-272.
53. Miyamoto M (1997). Characteristics of age-related behavioral changes in senescence-accelerated mouse SAMP8 and SAMP10. Exp Gerontol, 32: 139-148.
54. Okuma Y, Murayama T, Tha KK, Yamada C, Hosokawa M, Ishikawa A, Watanabe R, Maekawa M, Nomura Y (2000). Learning deficiency and alterations in acetylcholine receptors and protein kinase C in the brain of senescence-accelerated mouse (SAM)-P10. Mech Ageing Dev, 114: 191-199.
55. Onodera T, Watanabe R, Tha KK, Hayashi Y, Murayama T, Okuma Y, Ono C, Oketani Y, Hosokawa M, Nomura Y (2000). Depressive behavior and alterations in receptors for dopamine and 5-hydroxytryptamine in the brain of the senescence accelerated mouse (SAM)-P10. Jpn J Pharmacol, 83: 312-318.
56. Nie K, Yu JC, Fu Y, Cheng HY, Chen FY, Qu Y, Han JX (2009). Age-related decrease in constructive activation of Akt/PKB in SAMP10 hippocampus. Biochem Biophys Res Commun, 378: 103-107.
57. Chida Y, Sudo N, Mori J, Kubo C (2006). Social isolation stress impairs passive avoidance learning in senescence-accelerated mouse (SAM). Brain Res, 1067: 201-208.
58. Lucassen PJ, Chung WC, Kamphorst W, Swaab DF (1997). DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol, 56: 887-900.
59. Stadelmann C, Bruck W, Bancher C, Jellinger K, Lassmann H (1998). Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol, 57: 456-464.
60. Shimada A, Keino H, Satoh M, Kishikawa M, Seriu N, Hosokawa M (2002). Age-related progressive neuronal DNA damage associated with cerebral degeneration in a mouse model of accelerated senescence. J Gerontol A Biol Sci Med Sci, 57: B415-421.
61. Shimada A, Keino H, Kawamura N, Chiba Y, Hosokawa M (2008). Limbic structures are prone to age-related impairments in proteasome activity and neuronal ubiquitinated inclusions in SAMP10 mouse: a model of cerebral degeneration. Neuropathol Appl Neurobiol, 34: 33-51.
62. de Vrij FMS, Sluijs JA, Gregori L, Fischer D, Hermens WT, Goldgaber D, Verhaagen J, van Leeuwen FW, Hol EM (2001). Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death. FASEB J, 15: 2680-2688.
63. Hernandez F, Diaz-Hernandez M, Avila J, Lucas JJ (2004). Testing the ubiquitin-proteasome hypothesis of neurodegeneration in vivo. Trends Neurosci, 27: 66-69.
64. Petrucelli L, Dawson TM (2004). Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system. Ann Med, 36: 315-320.
65. Vigouroux S, Briand M, Briand Y (2004). Linkage between the proteasome pathway and neurodegenerative diseases and aging. Mol Neurobiol, 30: 201-221.
66. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW (1991). The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex, 1: 103-116.
67. Arriagada PV, MarzloffK, Hyman BT (1992). Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology, 42: 1681-1688.
68. Braak H, Braak E (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl), 82: 239-259.
69. Hof PR, Giannakopoulos P, Vickers JC, Bouras C, Morrison JH (1995). The morphologic and neurochemical basis of dementia: aging, hierarchical patterns of lesion distribution and vulnerable neuronal phenotype. Rev Neurosci, 6: 97-124.
70. Hof PR, Morrison JH (2004). The aging brain: morphomolecular senescence of cortical circuits. Trends Neurosci, 27: 607-613.
71. Hamburger V, Brunso-Bechtold JK, Yip JW (1981). Neuronal death in the spinal ganglia of the chick embryo and its reduction by nerve growth factor. J Neurosci, 1: 60-71.
72. Levi-Montalcini R (1987). The nerve growth factor: thirty-five years later. EMBO J, 6: 1145-1154.
73. Cuello AC, Bruno MA, Allard S, Leon W, Iulita MF (2010). Cholinergic involvement in Alzheimer's disease. A link with NGF maturation and degradation. J Mol Neurosci, 40: 230-235.
74. Larkfors L, Ebendal T, Whittemore SR, Persson H, Hoffer B, Olson L (1987). Decreased level of nerve growth factor (NGF) and its messenger RNA in the aged rat brain. Brain Res, 427: 55-60.
75. Cuello AC, Bruno MA, Bell KF (2007). NGF-cholinergic dependency in brain aging, MCI and Alzheimer's disease. Curr Alzheimer Res, 4: 351-358.
76. Ohnishi K, Tomimoto H, Akiguchi I, Seriu N, Kawamata T, Nakamura S, Kimura J, Nishio T, Higuchi K, Hosokawa M (1995). Age-related decrease of nerve growth factor-like immunoreactivity in the basal forebrain of senescence-accelerated mice. Acta Neuropathol, 90: 11-16.
77. Arenas E, Trupp M, Akerud P, Ibanez CF (1995). GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron, 15: 1465-1473.
78. Buj-Bello A, Buchman VL, Horton A, Rosenthal A, Davies AM (1995). GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron, 15: 821-828.
79. Hebert MA, Gerhardt GA (1997). Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. J Pharmacol Exp Ther, 282: 760-768.
80. Bowenkamp KE, Ujhelyi L, Cline EJ, Bickford PC (2000). Effects of intra-striatal GDNF on motor coordination and striatal electrophysiology in aged F344 rats. Neurobiol Aging, 21: 117-124.
81. Fox CM, Gash DM, Smoot MK, Cass WA (2001). Neuroprotective effects of GDNF against 6-OHDA in young and aged rats. Brain Res, 896: 56-63.
82. Miyazaki H, Okuma Y, Nomura J, Nagashima K, Nomura Y (2003). Age-related alterations in the expression of glial cell line-derived neurotrophic factor in the senescence-accelerated mouse brain. J Pharmacol Sci, 92: 28-34.
83. Nakanishi H, Miyazaki M, Takai N, Wang HD, Yamamoto T, Watanabe S, Yamamoto K (1998). Hyperexcitability of amygdala neurons of senescence-accelerated mouse revealed by electrical and optical recordings in an in vitro slice preparation. Brain Res, 812: 142-149.
84. Carter TA, Greenhall JA, Yoshida S, Fuchs S, Helton R, Swaroop A, Lockhart DJ, Barlow C (2005). Mechanisms of aging in senescence-accelerated mice. Genome Biol, 6: R48.
85. Thorns V, Licastro F, Masliah E (2001). Locally reduced levels of acidic FGF lead to decreased expression of 28-kda calbindin and contribute to the selective vulnerability of the neurons in the entorhinal cortex in Alzheimer's disease. Neuropathology, 21: 203-211.
86. Cuajungco MP, Lees GJ (1997). Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiol Dis, 4: 137-169.
87. Frederickson CJ (1989). Neurobiology of zinc and zinc-containing neurons. Int Rev Neurobiol, 31: 145-238.
88. Assaf SY, Chung SH (1984). Release of endogenous Zn2+ from brain tissue during activity. Nature, 308: 734-736.
89. Charton G, Rovira C, Ben-Ari Y, Leviel V (1985). Spontaneous and evoked release of endogenous Zn2+ in the hippocampal mossy fiber zone of the rat in situ. Exp Brain Res, 58: 202-205.
90. Westergaard N, Banke T, Wahl P, Sonnewald U, Schousboe A (1995). Citrate modulates the regulation by Zn2+ of N-methyl-D-aspartate receptor-mediated channel current and neurotransmitter release. Proc Natl Acad Sci U S A, 92: 3367-3370.
91. Peters S, Koh J, Choi DW (1987). Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons. Science, 236: 589-593.
92. Westbrook GL, Mayer ML (1987). Micromolar concentrations of Zn2+ antagonize NMDA and GABA responses of hippocampal neurons. Nature, 328: 640-643.
93. Barili P, Fringuelli C, Ricci A, Rossodivita I, Sabbatini M (1997). Age-related changes of sulphide-silver staining in the rat hippocampus. Mech Ageing Dev, 99: 83-94.
94. Palmiter RD, Cole TB, Quaife CJ, Findley SD (1996). ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci U S A, 93: 14934-14939.
95. Saito T, Takahashi K, Nakagawa N, Hosokawa T, Kurasaki M, Yamanoshita O, Yamamoto Y, Sasaki H, Nagashima K, Fujita H (2000). Deficiencies of hippocampal Zn and ZnT3 accelerate brain aging of Rat. Biochem Biophys Res Commun, 279: 505-511.
96. Testi R (1996). Sphingomyelin breakdown and cell fate. Trends Biochem Sci, 21: 468-471.
97. Sallusto F, Nicolo C, De Maria R, Corinti S, Testi R (1996). Ceramide inhibits antigen uptake and presentation by dendritic cells. J Exp Med, 184: 2411-2416.
98. Venable ME, Lee JY, Smyth MJ, Bielawska A, Obeid LM (1995). Role of ceramide in cellular senescence. J Biol Chem, 270: 30701-30708.
99. Galtrey CM, Fawcett JW (2007). The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev, 54: 1-18.
100. Saitoh Y, Matsui F, Chiba Y, Kawamura N, Keino H, Satoh M, Kumagai N, Ishii S, Yoshikawa K, Shimada A, Maeda N, Oohira A, Hosokawa M (2008). Reduced expression of MAb6B4 epitopes on chondroitin sulfate proteoglycan aggrecan in perineuronal nets from cerebral cortices of SAMP10 mice: a model for age-dependent neurodegeneration. J Neurosci Res, 86: 1316-1323.
101. Saitoh Y, Chiba Y, Shimada A. (2007). Aging and proteoglycans. In: Maeda N, editor. Neural proteoglycans. Kerala, India: Research Signpost, 183-199.
102. Furukawa A, Oikawa S, Hasegawa-Ishii S, Chiba Y, Kawamura N, Takei S, Yoshikawa K, Hosokawa M, Kawanishi S, Shimada A (2010). Proteomic analysis of aging brain in SAMP10 mouse: A model of age-related cerebral degeneration. Mech Ageing Dev, 131: 379-388.
103. Hwang IK, Yoo KY, Kim do H, Lee BH, Kwon YG, Won MH (2007). Time course of changes in pyridoxal 5'-phosphate (vitamin B6 active form) and its neuroprotection in experimental ischemic damage. Exp Neurol, 206: 114-125.
104. Soutar MP, Thornhill P, Cole AR, Sutherland C (2009). Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development? Curr Alzheimer Res, 6: 269-278.
105. Cairns NJ, Zhukareva V, Uryu K, Zhang B, Bigio E, Mackenzie IR, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Lee VM, Trojanowski JQ (2004). alpha-Internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am J Pathol, 164: 2153-2161.
106. Harman D (1956). Aging: a theory based on free radical and radiation chemistry. J Gerontol, 11: 298-300.
107. Harman D (2001). Aging: overview. Ann N Y Acad Sci, 928: 1-21.
108. Kregel KC, Zhang HJ (2007). An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol, 292: R18-36.
109. Chiba Y, Shimada A, Kumagai N, Yoshikawa K, Ishii S, Furukawa A, Takei S, Sakura M, Kawamura N, Hosokawa M (2009). The senescence-accelerated mouse (SAM): a higher oxidative stress and age-dependent degenerative diseases model. Neurochem Res, 34: 679-687.
110. Sasaki T, Unno K, Tahara S, Shimada A, Chiba Y, Hoshino M, Kaneko T (2008). Age-related increase of superoxide generation in the brains of mammals and birds. Aging Cell, 7: 459-469.
111. Unno K, Takabayashi F, Kishido T, Oku N (2004). Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10). Exp Gerontol, 39: 1027-1034.
112. Kishido T, Unno K, Yoshida H, Choba D, Fukutomi R, Asahina S, Iguchi K, Oku N, Hoshino M (2007). Decline in glutathione peroxidase activity is a reason for brain senescence: consumption of green tea catechin prevents the decline in its activity and protein oxidative damage in ageing mouse brain. Biogerontology, 8: 423-430.
113. Brunk UT, Jones CB, Sohal RS (1992). A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis. Mutat Res, 275: 395-403.
114. Numata T, Saito T, Maekawa K, Takahashi Y, Saitoh H, Hosokawa T, Fujita H, Kurasaki M (2002). Bcl-2-linked apoptosis due to increase in NO synthase in brain of SAMP10. Biochem Biophys Res Commun, 297: 517-522.
115. Tha KK, Okuma Y, Miyazaki H, Murayama T, Uehara T, Hatakeyama R, Hayashi Y, Nomura Y (2000). Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Res, 885: 25-31.
116. Kumagai N, Chiba Y, Hosono M, Fujii M, Kawamura N, Keino H, Yoshikawa K, Ishii S, Saitoh Y, Satoh M, Shimada A, Hosokawa M (2007). Involvement of pro-inflammatory cytokines and microglia in an age-associated neurodegeneration model, the SAMP10 mouse. Brain Res, 1185: 75-85.
117. Hasegawa-Ishii S, Takei S, Chiba Y, Furukawa A, Umegaki H, Iguchi A, Kawamura N, Yoshikawa K, Hosokawa M, Shimada A (2011). Morphological impairments in microglia precede age-related neuronal degeneration in senescence-accelerated mice. Neuropathology, 31: 20-28.
118. Sakai H, Saku T, Kato Y, Yamamoto K (1989). Quantitation and immunohistochemical localization of cathepsins E and D in rat tissues and blood cells. Biochim Biophys Acta, 991: 367-375.
119. Yagi H, Irino M, Matsushita T, Katoh S, Umezawa M, Tsuboyama T, Hosokawa M, Akiguchi I, Tokunaga R, Takeda T (1989). Spontaneous spongy degeneration of the brain stem in SAM-P/8 mice, a newly developed memory-deficient strain. J Neuropathol Exp Neurol, 48: 577-590.
120. Carp RI, Meeker HC, Chung R, Kozak CA, Hosokawa M, Fujisawa H (2002). Murine leukemia virus in organs of senescence-prone and -resistant mouse strains. Mech Ageing Dev, 123: 575-584.
121. Kim BH, Meeker HC, Shin HY, Kim JI, Jeong BH, Choi EK, Carp RI, Kim YS (2008). Physiological properties of astroglial cell lines derived from mice with high (SAMP8) and low (SAMR1, ICR) levels of endogenous retrovirus. Retrovirology, 5: 104.
122. Jeong BH, Jin JK, Choi EK, Lee EY, Meeker HC, Kozak CA, Carp RI, Kim YS (2002). Analysis of the expression of endogenous murine leukemia viruses in the brains of senescence-accelerated mice (SAMP8) and the relationship between expression and brain histopathology. J Neuropathol Exp Neurol, 61: 1001-1012.
123. Kay DG, Gravel C, Robitaille Y, Jolicoeur P (1991). Retrovirus-induced spongiform myeloencephalopathy in mice: regional distribution of infected target cells and neuronal loss occurring in the absence of viral expression in neurons. Proc Natl Acad Sci U S A, 88: 1281-1285.
124. Gravel C, Kay DG, Jolicoeur P (1993). Identification of the infected target cell type in spongiform myeloencephalopathy induced by the neurotropic Cas-Br-E murine leukemia virus. J Virol, 67: 6648-6658.
125. Clase AC, DimcheffDE, Favara C, Dorward D, McAtee FJ, Parrie LE, Ron D, Portis JL (2006). Oligodendrocytes are a major target of the toxicity of spongiogenic murine retroviruses. Am J Pathol, 169: 1026-1038.
126. Jorgensen MB, Finsen BR, Jensen MB, Castellano B, Diemer NH, Zimmer J (1993). Microglial and astroglial reactions to ischemic and kainic acid-induced lesions of the adult rat hippocampus. Exp Neurol, 120: 70-88.
127. Hasegawa-Ishii S, Takei S, Inaba M, Umegaki H, Chiba Y, Furukawa A, Kawamura N, Hosokawa M, Shimada A (2011). Defects in cytokine-mediated neuroprotective glial responses to excitotoxic hippocampal injury in senescence-accelerated mouse. Brain Behav Immun, 25: 83-100.
128. Gessani S, Belardelli F (1998). IFN-gamma expression in macrophages and its possible biological significance. Cytokine Growth Factor Rev, 9: 117-123.
129. Kawanokuchi J, Mizuno T, Takeuchi H, Kato H, Wang J, Mitsuma N, Suzumura A (2006). Production of interferon-gamma by microglia. Mult Scler, 12: 558-564.
130. Wang X, Suzuki Y (2007). Microglia produce IFN-gamma independently from T cells during acute toxoplasmosis in the brain. J Interferon Cytokine Res, 27: 599-605.
131. Wang Y, Zhou CF (2005). Involvement of interferon-gamma and its receptor in the activation of astrocytes in the mouse hippocampus following entorhinal deafferentation. Glia, 50: 56-65.
132. Amin DN, Rottenberg ME, Thomsen AR, Mumba D, Fenger C, Kristensson K, Buscher P, Finsen B, Masocha W (2009). Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis. J Infect Dis, 200: 1556-1565.
133. Bhowmick S, Duseja R, Das S, Appaiahgiri MB, Vrati S, Basu A (2007). Induction of IP-10 (CXCL10) in astrocytes following Japanese encephalitis. Neurosci Lett, 414: 45-50.
134. RansohoffRM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Tuohy VK (1993). Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J, 7: 592-600.
135. Bakhiet M, Mousa A, Seiger A, Andersson J (2002). Constitutive and inflammatory induction of alpha and beta chemokines in human first trimester forebrain astrocytes and neurons. Mol Immunol, 38: 921-929.
136. Carr DJ, Chodosh J, Ash J, Lane TE (2003). Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J Virol, 77: 10037-10046.
137. Wang HK, Park UJ, Kim SY, Lee JH, Kim SU, Gwag BJ, Lee YB (2008). Free radical production in CA1 neurons induces MIP-1alpha expression, microglia recruitment, and delayed neuronal death after transient forebrain ischemia. J Neurosci, 28: 1721-1727.
138. Rappert A, Bechmann I, Pivneva T, Mahlo J, Biber K, Nolte C, Kovac AD, Gerard C, Boddeke HW, Nitsch R, Kettenmann H (2004). CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci, 24: 8500-8509.
139. Tambuyzer BR, Ponsaerts P, Nouwen EJ (2009). Microglia: gatekeepers of central nervous system immunology. J Leukoc Biol, 85: 352-370.
140. Hanisch UK (2002). Microglia as a source and target of cytokines. Glia, 40: 140-155.
141. Ottonello L, Montecucco F, Bertolotto M, Arduino N, Mancini M, Corcione A, Pistoia V, Dallegri F (2005). CCL3 (MIP-1alpha) induces in vitro migration of GM-CSF-primed human neutrophils via CCR5-dependent activation of ERK 1/2. Cell Signal, 17: 355-363.
142. Kim SY, Choi YS, Choi JS, Cha JH, Kim ON, Lee SB, Chung JW, Chun MH, Lee MY (2002). Osteopontin in kainic acid-induced microglial reactions in the rat brain. Mol Cells, 13: 429-435.
143. Choi JS, Kim HY, Cha JH, Choi JY, Lee MY (2007). Transient microglial and prolonged astroglial upregulation of osteopontin following transient forebrain ischemia in rats. Brain Res, 1151: 195-202.
144. Wang X, Louden C, Yue TL, Ellison JA, Barone FC, Solleveld HA, Feuerstein GZ (1998). Delayed expression of osteopontin after focal stroke in the rat. J Neurosci, 18: 2075-2083.
145. Meller R, Stevens SL, Minami M, Cameron JA, King S, Rosenzweig H, Doyle K, Lessov NS, Simon RP, Stenzel-Poore MP (2005). Neuroprotection by osteopontin in stroke. J Cereb Blood Flow Metab, 25: 217-225.
146. Schroeter M, Zickler P, Denhardt DT, Hartung HP, Jander S (2006). Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice. Brain, 129: 1426-1437.
147. Ellison JA, Velier JJ, Spera P, Jonak ZL, Wang X, Barone FC, Feuerstein GZ (1998). Osteopontin and its integrin receptor alpha(v)beta3 are upregulated during formation of the glial scar after focal stroke. Stroke, 29: 1698-1706; discussion 1707.
148. Lin YH, Huang CJ, Chao JR, Chen ST, Lee SF, Yen JJ, Yang-Yen HF (2000). Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor. Mol Cell Biol, 20: 2734-2742.
149. Maetzler W, Berg D, Funke C, Sandmann F, Stunitz H, Maetzler C, Nitsch C (2010). Progressive secondary neurodegeneration and microcalcification co-occur in osteopontin-deficient mice. Am J Pathol, 177: 829-839
150. Bausch SB (2006). Potential roles for hyaluronan and CD44 in kainic acid-induced mossy fiber sprouting in organotypic hippocampal slice cultures. Neuroscience, 143: 339-350.
151. Borges K, McDermott DL, Dingledine R (2004). Reciprocal changes of CD44 and GAP-43 expression in the dentate gyrus inner molecular layer after status epilepticus in mice. Exp Neurol, 188: 1-10.
152. Ries A, Goldberg JL, Grimpe B (2007). A novel biological function for CD44 in axon growth of retinal ganglion cells identified by a bioinformatics approach. J Neurochem, 103: 1491-1505.
153. Hasegawa S, Yamaguchi M, Nagao H, Mishina M, Mori K (2007). Enhanced cell-to-cell contacts between activated microglia and pyramidal cell dendrites following kainic acid-induced neurotoxicity in the hippocampus. J Neuroimmunol, 186: 75-85.
154. Neumann J, Gunzer M, Gutzeit HO, Ullrich O, Reymann KG, Dinkel K (2006). Microglia provide neuroprotection after ischemia. FASEB J, 20: 714-716.
155. Wilson EH, Weninger W, Hunter CA (2010). Trafficking of immune cells in the central nervous system. J Clin Invest, 120: 1368-1379.
156. Ban E, Haour F, Lenstra R (1992). Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine, 4: 48-54.
157. Laye S, Parnet P, Goujon E, Dantzer R (1994). Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res Mol Brain Res, 27: 157-162.
158. Van Dam AM, Bauer J, Tilders FJ, Berkenbosch F (1995). Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience, 65: 815-826.
159. van Dam AM, Brouns M, Louisse S, Berkenbosch F (1992). Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Res, 588: 291-296.
160. Williams K, Alvarez X, Lackner AA (2001). Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia, 36: 156-164.
161. Serrats J, Schiltz JC, Garcia-Bueno B, van Rooijen N, Reyes TM, Sawchenko PE (2010). Dual roles for perivascular macrophages in immune-to-brain signaling. Neuron, 65: 94-106.
162. Nataf S, Strazielle N, Hatterer E, Mouchiroud G, Belin MF, Ghersi-Egea JF (2006). Rat choroid plexuses contain myeloid progenitors capable of differentiation toward macrophage or dendritic cell phenotypes. Glia, 54: 160-171.
163. Chinnery HR, Ruitenberg MJ, McMenamin PG (2010). Novel characterization of monocyte-derived cell populations in the meninges and choroid plexus and their rates of replenishment in bone marrow chimeric mice. J Neuropathol Exp Neurol, 69: 896-909.
164. Prodinger C, Bunse J, Kruger M, Schiefenhovel F, Brandt C, Laman JD, Greter M, Immig K, Heppner F, Becher B, Bechmann I (2011). CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol, 121: 445-458.
165. Kipnis J, Derecki NC, Yang C, Scrable H (2008). Immunity and cognition: what do age-related dementia, HIV-dementia and 'chemo-brain' have in common? Trends Immunol, 29: 455-463.
166. Brynskikh A, Warren T, Zhu J, Kipnis J (2008). Adaptive immunity affects learning behavior in mice. Brain Behav Immun, 22: 861-869.
167. Derecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A, Lynch KR, Kipnis J (2010). Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med, 207: 1067-1080.
168. Cohen N, Kinney KS (2007). Exploring the phylogenetic history of neural-immune system interactions: an update. In: Ader R, editor. Psychoneuroimmunology. 4th edn. Amsterdam: Elsevier Academic Press, 1-38.